The Royal Marsden is the world's first hospital dedicated to cancer, founded in 1851. Operating from Chelsea and Sutton, it treats over 59,000 patients annually through specialist units for every cancer type, combining clinical care with pioneering research. Rated Outstanding by the CQC and ranked in the top five cancer centres worldwide, it delivers surgery, chemotherapy, radiotherapy and immunotherapy alongside clinical trials. The hospital leads innovation in precision medicine and new treatments that shape global cancer care. As a National Institute for Health and Care Research Biomedical Research Centre in partnership with the Institute of Cancer Research, it translates laboratory discoveries into patient therapies and trains the next generation of cancer specialists.
4837
Team Members
1851
Founded
NHS
Sector
On-Site
Work Environment
To lead the way in transforming how cancer is understood and treated, shaping care globally and driving innovation to improve patient outcomes and the future of cancer care.
To provide specialist cancer diagnosis, treatment, research and education, delivering the highest quality care while pioneering innovation that improves outcomes for people affected by cancer.